These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 304178)

  • 41. [Dynamic sampling analysis of the immune status of breast cancer patients].
    Eremina OF; Kunitsyna TA; Sharonina AI
    Vopr Onkol; 1985; 31(6):33-7. PubMed ID: 3875181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Possibility of using tumor markers, pituitary gonadotropic hormones and prolactin in the diagnosis of breast cancer].
    Korolev VI; Skliar SIu; Chebotareva ED; Akimova RN
    Vopr Onkol; 1986; 32(11):55-9. PubMed ID: 3788082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "High-affinity" T-cell rosettes: the effects of clinical manipulations and potential prognostic significance.
    Weese JL; West WH; Herberman RB; Payne SM; Siwarski JW; Turcotte JG
    J Surg Oncol; 1980; 13(2):145-53. PubMed ID: 6965745
    [No Abstract]   [Full Text] [Related]  

  • 44. [Radioimmunologic analysis of ferritin, carcinoembryonic antigen and prolactin for evaluating the prognosis and effectiveness of treating breast cancer].
    Skliar SIu; Chebotareva ED; Ganul VL; Korolev VI
    Med Radiol (Mosk); 1987 Oct; 32(10):32-6. PubMed ID: 3657434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [What value should be given to assays of serum ferritin in breast cancers? Correlation with various biological parameters].
    Dalifard I; Daver A; Cellier P; Larra F
    Sem Hop; 1984 Jan; 60(3):157-62. PubMed ID: 6320439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Carcinoembryonic antigen and immunity in breast cancer].
    Iakimova TP; Lozinskaia IN; Kozyreva TB; Pashchenko NS
    Med Radiol (Mosk); 1991; 36(10):15-7. PubMed ID: 1943545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Stimulation of the immunological reactivity of cancer patients by Eleutherococcus extract].
    Kupin VI; Polevaia EB
    Vopr Onkol; 1986; 32(7):21-6. PubMed ID: 3526720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The value of evaluating tumor markers: CA 15-3 and ferritin in blood serum of patients grouped as "high risk" for breast cancer].
    Kokocińska D; Widala E; Donocik J; Nolewajka E
    Przegl Lek; 1999; 56(10):664-7. PubMed ID: 10695382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-cell markers in breast cancer patients at diagnosis.
    Goust JM; Roof BS; Fudenberg HH; O'Brien PH
    Clin Immunol Immunopathol; 1979 Apr; 12(4):396-403. PubMed ID: 313292
    [No Abstract]   [Full Text] [Related]  

  • 50. [Activity of non-specific T-suppressors regulating the proliferation of B- and T-lymphocytes in patients with fibroadenomatosis, breast cancer and stomach cancer].
    Grinevich IuA; Drannik GN; Nikol'skiĭ IS; Kalinina NA; Litvishchenko EI
    Vopr Onkol; 1984; 30(12):23-7. PubMed ID: 6240157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Initial immunologic evaluations in breast and thyroid cancer].
    Abeatici S; Mussa A; Levis P; Sandrucci S; Storta P
    Minerva Med; 1982 Apr; 73(18):1149-54. PubMed ID: 6979010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of ferritin, CEA and AFP in patients operated on for carcinoma of the breast. Preliminary results].
    Latteri M; Spinnato G; Pantuso G; Di Lisi G; Latteri S; Bellanca L; Latteri MT; Cirello B; Ciaccio M
    Minerva Chir; 1987 May; 42(10):911-6. PubMed ID: 2442669
    [No Abstract]   [Full Text] [Related]  

  • 53. Significance of thymus-dependent lymphocytes in the biology of human breast cancer.
    Barr RD; McCulloch PB
    Can J Surg; 1979 Nov; 22(6):503-4. PubMed ID: 315259
    [No Abstract]   [Full Text] [Related]  

  • 54. [Determination of TAA-binding cells in peripheral blood of breast cancer patients (author's transl)].
    Sauer H; Kraus I; Seliger C; Preusse C; Ambrosius H
    Allerg Immunol (Leipz); 1980; 26(4):368-74. PubMed ID: 6452045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Serum levels of 4 tumor-associated antigens in the evaluation of the spread of breast carcinoma].
    Stefanović L; Kamenjicki E; Selir Z; Miljković L; Sterio B; Semnic R; Sljapić N
    Med Pregl; 1984; 37(3-4):107-12. PubMed ID: 6208469
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breast.
    Kher A; Moghe G; Deshpande A
    Indian J Pathol Microbiol; 1997 Jul; 40(3):321-6. PubMed ID: 9354001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Specific features of endogenous autorosette formation in the peripheral blood of cancer patients].
    Korichkina LN; Lavrinenko LV; Vinogradova TS; Salova NV; Gusakova GV
    Vopr Onkol; 2008; 54(1):62-4. PubMed ID: 18416060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ferritin-bearing lymphocytes in patients with cancer.
    Papenhausen PR; Emeson EE; Croft CB; Borowiecki B
    Cancer; 1984 Jan; 53(2):267-71. PubMed ID: 6360336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum ferritin concentration in early breast cancer.
    Jacobs A; Jones B; Ricketts C; Bulbrook RD; Wang DY
    Br J Cancer; 1976 Sep; 34(3):286-90. PubMed ID: 974002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.